The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
MicroRNA in diagnosis and therapy monitoring of early-stage triple-negative breast cancer
Open accessAbstract
Breast cancer is a heterogeneous disease with distinct molecular subtypes including the aggressive subtype triple-negative breast cancer (TNBC). We compared blood-borne miRNA signatures of early-stage basal-like (cytokeratin-CK5-positive) TNBC patients to age-matched controls. The miRNAs of TNBC patients were assessed prior to and following platinum-based neoadjuvant chemotherapy (NCT). After an exploratory genome-wide study on 21 cases and 21 controls using microarrays, the identified signatures were verified independently in two laboratories on the same and a new cohort by RT-qPCR. We differentiated the blood of TNBC patients before NCT from controls with 84% sensitivity. The most significant miRNA for this diagnostic classification was miR-126-5p (two tailed t-test p-value of 1.4 × 10−5). Validation confirmed the microarray results for all tested miRNAs. Comparing cancer patients prior to and post NCT highlighted 321 significant miRNAs (among them miR-34a, p-value of 1.2 × 10−23). Our results also suggest that changes in miRNA expression during NCT may have predictive potential to predict pathological complete response (pCR). In conclusion we report that miRNA expression measured from blood facilitates early and minimally-invasive diagnosis of basal-like TNBC. We also demonstrate that NCT has a significant influence on miRNA expression. Finally, we show that blood-borne miRNA profiles monitored over time have potential to predict pCR.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Distribution of miRNA expression across human tissues
Ludwig, N., Leidinger, P., Becker, K., Backes, C., Fehlmann, T., Pallasch, C., Rheinheimer, S., Meder, B., Stähler, C., Meese, E., et al. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw116 · Cited by 968
Self-citationToward the blood-borne miRNome of human diseases
Keller, A., Leidinger, P., Bauer, A., ElSharawy, A., Haas, J., Backes, C., Wendschlag, A., Giese, N., Tjaden, C., Ott, K., et al. (2011) · Nature Methods · doi:10.1038/nmeth.1682 · Cited by 355
Self-citationThe human miRNA repertoire of different blood compounds
Leidinger, P., Backes, C., Meder, B., Meese, E., & Keller, A. (2014) · BMC Genomics · doi:10.1186/1471-2164-15-474 · Cited by 67
Self-citation
Cited by
Advances in multiplexed techniques for the detection and quantification of microRNAs
Jet, T., Gines, G., Rondelez, Y., & Taly, V. (2021) · Chemical Society Reviews · doi:10.1039/d0cs00609b · Cited by 453
Breast cancer: miRNAs monitoring chemoresistance and systemic therapy
Singh, S., Saini, H., Sharma, A., Gupta, S., Huddar, V. G., & Tripathi, R. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1155254 · Cited by 25
Metadata
- Authors
- Kahraman, M., Röske, A., Laufer, T., Fehlmann, T., Backes, C., Kern, F., Kohlhaas, J., Schrörs, H., Saiz, A., Zabler, C., Ludwig, N., Fasching, P. A., Strick, R., Rübner, M., Beckmann, M. W., Meese, E., Keller, A., & Schrauder, M. G.
- Venue
- Scientific Reports
- Published
- 2018-08-02
- Volume
- 8
- Issue
- 1
- Pages
- 11584-11584
- ISSN
- 2045-2322 (ISSN-L)
- OpenAlex
- W2884244088
- Cited by
- 158
- References
- 3
- FWCI
- 4.74
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: MicroRNA in diagnosis and therapy monitoring of early-stage triple-negative breast cancer. https://app.cochat.ai/papers/10.1038/s41598-018-29917-2
- The paper
- Kahraman, M., Röske, A., Laufer, T., Fehlmann, T., Backes, C., Kern, F., Kohlhaas, J., Schrörs, H., Saiz, A., Zabler, C., Ludwig, N., Fasching, P. A., Strick, R., Rübner, M., Beckmann, M. W., Meese, E., Keller, A., & Schrauder, M. G. (2018). MicroRNA in diagnosis and therapy monitoring of early-stage triple-negative breast cancer. Scientific Reports. https://doi.org/10.1038/s41598-018-29917-2
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.